Avenda Health, an AI startup bringing personalization to prostate cancer care, raised $10 million in Series B funding led by VCapital, the parties tell Axios exclusively.
Why it matters: Prostate cancer is the second most common cancer in men, but scientific advancements to treat the disease have dramatically lagged other areas of oncology. With technology, Culver City's Avenda hopes to preserve diagnosed patients' quality of life.
